Back to Top
Rituximab Biosimilar N297A Research Grade
Add recommended extras
Rituximab Biosimilar N297A Research Grade
| Concentration | 1.0 - 5.0 mg/ml |
|---|---|
| Isotype | Human IgG1 (N297A)-Kappa |
| Host | CHO Cells |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rituximab. |
| Species Reactivity | Human |
| Target | CD20 |
| Shipping Conditions | Blue ice |
| background | Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary). |
| Other names | MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7 |
| UniProt | P11836 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |
Write Your Own Review
Who Viewed This Also Viewed
Anti-CD115 (AFS98) In Vivo Antibody - Low Endotoxin
$390.00 - $3,702.00
Anti-CD278 (7E.17G9) In Vivo Antibody - Low Endotoxin
$390.00 - $3,702.00
Farletuzumab Vedotin Biosimilar - Research Grade
$700.00 - $3,024.00
